Cargando…
Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an overall five-year survival rate of less than twenty percent. For patients with unresectable disease, evolving liver-directed locoregional therapies provide efficacious treatment across the spectrum of disease st...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613749/ https://www.ncbi.nlm.nih.gov/pubmed/34887643 http://dx.doi.org/10.3748/wjg.v27.i43.7462 |